Latest period
$6.75B
YoY change
-13.4%
5Y CAGR
-1.6%
Peak year (2024)
$7.27B
Latest annual
$6.29B
Free Cash Flow history chart for Thermo Fisher Scientific (TMO) from 1989 to 2025
Latest: $6.29B
Free Cash Flow growth chart for Thermo Fisher Scientific (TMO) from 1989 to 2025
Latest: -13.4%
Free Cash Flow history table for Thermo Fisher Scientific (TMO) from 1989 to 2025
| 2025 | $6.29B | -13.4% | −$974.00M | ||
| 2024 | $7.27B | +4.9% | +$340.00M | ||
| 2023 | $6.93B | +0.2% | +$16.00M | ||
| 2022 | $6.91B | -1.6% | −$109.00M | ||
| 2021 | $7.02B | +3.0% | +$205.00M | ||
| 2020 | $6.82B | +68.4% | +$2.77B | ||
| 2019 | $4.05B | +6.9% | +$262.00M | ||
| 2018 | $3.79B | +8.2% | +$288.00M | ||
| 2017 | $3.50B | +29.0% | +$785.10M | ||
| 2016 | $2.71B | +13.3% | +$317.90M | ||
| 2015 | $2.39B | +9.2% | +$202.00M | ||
| 2014 | $2.19B | +26.8% | +$463.70M | ||
| 2013 | $1.73B | +0.2% | +$3.90M | ||
| 2012 | $1.72B | +21.1% | +$299.90M | ||
| 2011 | $1.42B | +15.6% | +$192.20M | ||
| 2010 | $1.23B | -15.1% | −$219.40M | ||
| 2009 | $1.45B | +25.6% | +$295.90M | ||
| 2008 | $1.16B | -11.6% | −$152.20M | ||
| 2007 | $1.31B | +297.7% | +$979.14M | ||
| 2006 | $328.86M | +44.6% | +$101.49M | ||
| 2005 | $227.37M | +6.0% | +$12.84M | ||
| 2004 | $214.53M | +25.8% | +$43.94M | ||
| 2003 | $170.58M | +230.1% | +$118.90M | ||
| 2002 | $51.68M | -50.1% | −$51.92M | ||
| 2001 | $103.60M | -17.7% | −$22.28M | ||
| 2000 | $125.88M | -183.4% | +$276.76M | ||
| 1999 | −$150.88M | +107.5% | −$78.18M | ||
| 1998 | −$72.70M | -89.5% | +$619.00M | ||
| 1997 | −$691.70M | -791.7% | −$791.70M | ||
| 1996 | $100.00M | -24.1% | −$31.70M | ||
| 1995 | $131.70M | -8.5% | −$12.30M | ||
| 1994 | $144.00M | +105.4% | +$73.90M | ||
| 1993 | $70.10M | -1474.5% | +$75.20M | ||
| 1992 | −$5.10M | -51.4% | +$5.40M | ||
| 1991 | −$10.50M | -89.6% | +$90.90M | ||
| 1990 | −$101.40M | +33700.0% | −$101.10M | ||
| 1989 | −$300.00K | — | — |
- 2025$6.29B-13.4%
- 2024$7.27B+4.9%
- 2023$6.93B+0.2%
- 2022$6.91B-1.6%
- 2021$7.02B+3.0%
- 2020$6.82B+68.4%
- 2019$4.05B+6.9%
- 2018$3.79B+8.2%
- 2017$3.50B+29.0%
- 2016$2.71B+13.3%
- 2015$2.39B+9.2%
- 2014$2.19B+26.8%
- 2013$1.73B+0.2%
- 2012$1.72B+21.1%
- 2011$1.42B+15.6%
- 2010$1.23B-15.1%
- 2009$1.45B+25.6%
- 2008$1.16B-11.6%
- 2007$1.31B+297.7%
- 2006$328.86M+44.6%
- 2005$227.37M+6.0%
- 2004$214.53M+25.8%
- 2003$170.58M+230.1%
- 2002$51.68M-50.1%
- 2001$103.60M-17.7%
- 2000$125.88M-183.4%
- 1999−$150.88M+107.5%
- 1998−$72.70M-89.5%
- 1997−$691.70M-791.7%
- 1996$100.00M-24.1%
- 1995$131.70M-8.5%
- 1994$144.00M+105.4%
- 1993$70.10M-1474.5%
- 1992−$5.10M-51.4%
- 1991−$10.50M-89.6%
- 1990−$101.40M+33700.0%
- 1989−$300.00K—
Free Cash Flow values are taken from Thermo Fisher Scientific's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Free Cash Flow at Thermo Fisher Scientific (TMO)
Free Cash Flow for Thermo Fisher Scientific (TMO): headline value $6.75B · YoY -13.4%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Thermo Fisher Scientific (TMO) reported free cash flow of $6.29B – declined 13.4% year-over-year.
Thermo Fisher Scientific free cash flow has contracted on net over the period, with a -1.6% compound annual growth rate over 2020–2025 (5 years).
Thermo Fisher Scientific free cash flow peaked at $7.27B in 2024; the latest annual figure is $6.29B in 2025 (13.4% below peak).
Across the available history, free cash flow reached its high of $7.27B in 2024 and its low of −$691.70M in 1997.
Thermo Fisher Scientific Free Cash Flow by Year
Thermo Fisher Scientific Free Cash Flow 2025: $6.29B
2025's free cash flow for Thermo Fisher Scientific came in at $6.29B, declined 13.4% below 2024.
Thermo Fisher Scientific Free Cash Flow 2024: $7.27B
Thermo Fisher Scientific posted free cash flow of $7.27B in 2024, edged up 4.9% from 2023. This figure represents the highest annual value in the available history.
Thermo Fisher Scientific Free Cash Flow 2023: $6.93B
In 2023, Thermo Fisher Scientific reported free cash flow of $6.93B, edged up 0.2% from 2022.
Thermo Fisher Scientific Free Cash Flow 2022: $6.91B
Thermo Fisher Scientific free cash flow in 2022 was $6.91B, edged down 1.6% below 2021.
Thermo Fisher Scientific Free Cash Flow 2021: $7.02B
Thermo Fisher Scientific free cash flow in 2021 was $7.02B.
See more financial history for Thermo Fisher Scientific (TMO).
Sector peers by Free Cash Flow
Healthcare peers of Thermo Fisher Scientific (TMO), ranked by their latest free cash flow
| $19.70B | |
| $17.82B | |
| $16.07B | |
| $12.36B | |
| $8.97B | |
| $8.67B | |
| $8.10B | |
| $4.52B |
- $19.70B
- $17.82B
- $16.07B
- $12.36B
- $8.97B
- $8.67B
- $8.10B
- $4.52B
Frequently asked questions
Thermo Fisher Scientific (TMO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation